CYTOKINE AND HORMONE INTERACTIONS IN COMORBIDITY OF AIDS

艾滋病合并症中细胞因子和激素的相互作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The anemia, neutropenia, loss of lean body mass and mortality of AIDS patients with wasting are associated with elevated levels of the proinflammatory cytokines TNFalpha and IL-1beta. AIDS patients with wasting are often given a 12- week therapy with very high doses of recombinant human growth hormone to increase plasma IGF-I, lean muscle mass and quality of life. However, the responsiveness of both hematopoietic and muscle cells to IGF-I has been documented to be defective in these patients. The central hypothesis of this application is that TNFalpha and IL-lbeta are responsible for inducing a state of IGF-I receptor resistance, which contributes to not only muscle wasting but also to the anemia and neutropenia of AIDS. IGF-I targets both hematopoietic myeloid progenitor cells and muscle myoblasts, and here we hypothesize that the molecular mechanism for IGF-I receptor resistance in wasting AIDS patients is caused by proinflammatory cytokines. Objective 1 will test the idea that IGF-I promotes promyeloid cell survival by blocking activation of the caspase family of serine proteases and whether this is inhibited by TNFa. Objective 2 focuses on the survival promoting activity of the tyrosine phosphorylated IGF-I receptor, including insulin-receptor substrate- 1 (IRS-1), IRS-2, PI 3-kinase and Akt. Objective 3 will determine if proinflammatory cytokines inhibit key IGF-I proliferative signals, including Shc, EFK1/2, AFX forkhead transcription factors and the cyclin-dependent kinase inhibitor 27. Finally, objective 4 will extend these results with myeloid progenitor cells to muscle myoblasts. Preliminary results indicate that low blood concentrations of TNFalpha and IL-1beta found in wasting AIDS patients inhibit the ability of IGF-I to promote both protein synthesis and differentiation into myotubes. This objective will also test the new idea that ceramide, a mediator of the actions of both TNFalpha and IL-1beta, induces resistance of the IGF-I receptor in muscle myoblasts. These studies are needed to understand how clinically-relevant concentrations of proinflammatory cytokines in wasting AIDS patients impair the functional ability of a major hormone receptor on both immune and muscle myoblast cells.
描述(由申请人提供):贫血、中性粒细胞减少、瘦体质丧失 艾滋病患者消瘦的质量和死亡率均与升高 促炎细胞因子TNF α和IL-1 β的水平。艾滋病患者 通常给予12周的高剂量重组 人生长激素增加血浆IGF-I,瘦肌肉质量和质量 生活然而,造血细胞和肌肉细胞对 IGF-I已被证明在这些患者中存在缺陷。中央 本申请假设是TNF α和IL-1 β负责 诱导IGF-I受体抗性的状态,这不仅有助于 肌肉萎缩,而且还导致艾滋病的贫血和中性粒细胞减少。IGF-I靶点 造血骨髓祖细胞和肌肉成肌细胞,在这里,我们 假设IGF-I受体抵抗的分子机制是 艾滋病患者的消瘦是由促炎细胞因子引起的。目标1将 测试IGF-I通过阻断 丝氨酸蛋白酶的半胱天冬酶家族的激活,以及这是否是 受到TNFa的抑制。目标2关注的是 酪氨酸磷酸化IGF-I受体,包括胰岛素受体 底物-1(IRS-1)、IRS-2、PI 3-激酶和Akt。目标3将确定 促炎细胞因子抑制关键的IGF-I增殖信号,包括 Shc、EFK 1/2、AFX叉头转录因子和细胞周期蛋白依赖性激酶 抑制剂27.最后,目标4将扩展这些结果与骨髓 祖细胞转化为成肌细胞。初步结果显示,低 在消瘦的艾滋病患者中发现的TNF α和IL-1 β的血液浓度抑制了 IGF-I促进蛋白质合成和分化为 肌管这一目标也将测试新的想法,神经酰胺,一个调解人 TNF α和IL-1 β的作用,诱导IGF-I受体的抵抗, 在肌肉成肌细胞中。需要这些研究来了解 消耗性艾滋病患者促炎细胞因子的临床相关浓度 患者损害了两个细胞上主要激素受体的功能能力, 免疫和肌肉成肌细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Keith W Kelley其他文献

Keith W Kelley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Keith W Kelley', 18)}}的其他基金

Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
衰老过程中抑郁样行为的神经免疫机制
  • 批准号:
    7588876
  • 财政年份:
    2007
  • 资助金额:
    $ 33.88万
  • 项目类别:
Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
衰老过程中抑郁样行为的神经免疫机制
  • 批准号:
    7986896
  • 财政年份:
    2007
  • 资助金额:
    $ 33.88万
  • 项目类别:
Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
衰老过程中抑郁样行为的神经免疫机制
  • 批准号:
    8049171
  • 财政年份:
    2007
  • 资助金额:
    $ 33.88万
  • 项目类别:
Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
衰老过程中抑郁样行为的神经免疫机制
  • 批准号:
    7795124
  • 财政年份:
    2007
  • 资助金额:
    $ 33.88万
  • 项目类别:
Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
衰老过程中抑郁样行为的神经免疫机制
  • 批准号:
    7174006
  • 财政年份:
    2007
  • 资助金额:
    $ 33.88万
  • 项目类别:
Neuroimmune Mechanisms of Depressive-Like Behavior During Aging
衰老过程中抑郁样行为的神经免疫机制
  • 批准号:
    7391645
  • 财政年份:
    2007
  • 资助金额:
    $ 33.88万
  • 项目类别:
CYTOKINE AND HORMONE INTERACTIONS IN COMORBIDITY OF AIDS
艾滋病合并症中细胞因子和激素的相互作用
  • 批准号:
    6604731
  • 财政年份:
    2002
  • 资助金额:
    $ 33.88万
  • 项目类别:
CYTOKINE AND HORMONE INTERACTIONS IN COMORBIDITY OF AIDS
艾滋病合并症中细胞因子和激素的相互作用
  • 批准号:
    6930551
  • 财政年份:
    2002
  • 资助金额:
    $ 33.88万
  • 项目类别:
CYTOKINE AND HORMONE INTERACTIONS IN COMORBIDITY OF AIDS
艾滋病合并症中细胞因子和激素的相互作用
  • 批准号:
    6495926
  • 财政年份:
    2002
  • 资助金额:
    $ 33.88万
  • 项目类别:
CYTOKINES, BEHAVIOR, AND MENTAL HEALTH
细胞因子、行为和心理健康
  • 批准号:
    2693408
  • 财政年份:
    1995
  • 资助金额:
    $ 33.88万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
FA/BRCA途径中siRNA干扰和PARP-1抑制剂对多药耐药骨髓瘤细胞株的影响
  • 批准号:
    81001053
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of ALK4 signaling in skeletal homeostasis and pathogenesis
ALK4 信号传导在骨骼稳态和发病机制中的作用
  • 批准号:
    10607071
  • 财政年份:
    2023
  • 资助金额:
    $ 33.88万
  • 项目类别:
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
阐明细胞识别和响应不同水平雄激素的机制
  • 批准号:
    10418461
  • 财政年份:
    2022
  • 资助金额:
    $ 33.88万
  • 项目类别:
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
骨髓纤维化的影像疾病异质性和治疗反应
  • 批准号:
    10360496
  • 财政年份:
    2019
  • 资助金额:
    $ 33.88万
  • 项目类别:
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
骨髓纤维化的影像疾病异质性和治疗反应
  • 批准号:
    9891988
  • 财政年份:
    2019
  • 资助金额:
    $ 33.88万
  • 项目类别:
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis
骨髓纤维化的影像疾病异质性和治疗反应
  • 批准号:
    10563197
  • 财政年份:
    2019
  • 资助金额:
    $ 33.88万
  • 项目类别:
Molecular Mechanisms of Muscle and Fat Wasting in Pancreatic Cancer Cachexia
胰腺癌恶病质中肌肉和脂肪消耗的分子机制
  • 批准号:
    10159842
  • 财政年份:
    2018
  • 资助金额:
    $ 33.88万
  • 项目类别:
Activin A antagonist for treatment of cancer-associated cachexia
激活素 A 拮抗剂用于治疗癌症相关恶病质
  • 批准号:
    9046615
  • 财政年份:
    2015
  • 资助金额:
    $ 33.88万
  • 项目类别:
Microbial translocation, inflammation, and adverse pregnancy outcomes in humans
人类微生物易位、炎症和不良妊娠结局
  • 批准号:
    9207123
  • 财政年份:
    2015
  • 资助金额:
    $ 33.88万
  • 项目类别:
The Multimodal Rehabilitation of Older Ventilated Survivors Of Critical Illness
老年危重疾病通气幸存者的多模式康复
  • 批准号:
    8556760
  • 财政年份:
    2013
  • 资助金额:
    $ 33.88万
  • 项目类别:
Impact of Pre-Natal Immune Sensitization on Childhood Morbidity
产前免疫敏化对儿童发病率的影响
  • 批准号:
    8517509
  • 财政年份:
    2013
  • 资助金额:
    $ 33.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了